Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681) |
---|
07/16/2002 | US6420343 Carbamate and carbazate ketolide antibiotics |
07/11/2002 | WO2002053573A1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
07/10/2002 | CN1358188A Diphosphate salt of A4'-substituted-9-deoxo-9A-aza 9A-homoerythromycin derivative and its pharmaceutical composition |
07/09/2002 | US6417366 Chemical intermediate for macrolactone antibiotic |
07/09/2002 | CA2270124C 9a,11b-dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin |
07/09/2002 | CA2244519C C-4":substituted macrolide antibiotics |
07/04/2002 | WO2002051855A2 Motilide compounds |
07/04/2002 | US20020086834 Flavonoid glycoside of given formula; extract of Cassia alata |
07/04/2002 | US20020086833 Cocoa procyanidin oligomer/polymer, a polyphenol-type compound; anticancer agent; antioxidant; DNA topoisomerase II enzyme inhibitors, cyclooxygenase, NO (Nitric Oxide) or NO-synthase modulators, nonsteroidal antiinflammatory agent |
07/04/2002 | CA2429709A1 Motilide compounds |
07/03/2002 | EP1219296A1 Sebum production inhibitors |
07/03/2002 | EP1218390A2 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same |
07/03/2002 | EP1003760A4 Prodrugs and conjugates of thiol- and selenol- containing compounds and methods of use thereof |
07/03/2002 | CN1357001A Novel ribose-substituted aromatic amides, method for prodn. and use thereof as medicaments |
07/03/2002 | CN1357000A Water soluble prodrugs of hindered alcohols or phenols |
07/03/2002 | CN1356981A Pharmaceutical compounds |
07/03/2002 | CN1356327A Process for extracting flavone from pomelo peel |
07/02/2002 | CA2109601C Amide derivatives of antibiotic a 40926 |
06/27/2002 | WO2002050093A2 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
06/27/2002 | WO2002050092A1 Macrolide antibiotics |
06/27/2002 | WO2002050091A1 Macrolide antibiotics |
06/27/2002 | CA2432429A1 Macrolide antibiotics |
06/26/2002 | EP1216256A1 Macrolide antibiotics and treatment of pasteurellosis |
06/26/2002 | EP0830137A4 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
06/26/2002 | CN1355713A Releasable bond and composition containing said bond |
06/25/2002 | US6410791 Salbutamol; respiratory system disorders |
06/25/2002 | US6410699 Generation of preferential isoflavone glycosides; obtain sample, remove fat from fermented soybeans, incubate with solvent to generate isoflavone glycoside extract, dissolve extract in solvent, wash and recover isoflavone glycoside |
06/20/2002 | WO2002048331A2 Active-site engineering of nucleotidyltransferases and enzymatic methods for the synthesis of natural and 'unnatural' udp- and nucleotide sugars |
06/20/2002 | WO2001083448A3 Novel prodrugs von 6-hydroxy-2,3-dihydro-1h-indoles, 5-hydroxy-1,2-dihydro-3h-pyrrolo[3,2-e]indoles and 5-hydroxy-1,2-dihydro-3h-benzo(e)indoles as well as of 6-hydroxy-1,2,3,4-tetrahydro-benzo[f]quinoline derivatives for use in selective cancer therapy |
06/20/2002 | US20020077302 Tricyclic erythromycin derivatives |
06/20/2002 | US20020077300 Assessing a candidate compound for its ability to inhibit mitochondrial ATP synthase, whereby a compound which is able to inhibit synthase is identified as compound that will selectively effect apoptosis in tumor |
06/19/2002 | EP1214308A2 Novel flavonoids |
06/19/2002 | EP0877750B1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents |
06/19/2002 | CN1354753A Novel intermediates, process for preparing macrolide antibiotic agent therefrom |
06/18/2002 | US6407257 Derivatives of erythromycin, their preparation process and their use as medicaments |
06/18/2002 | US6407074 Bactericides, antibiotics |
06/18/2002 | US6407073 Use of coumarin derivatives for the treatment of digestive tract disorders |
06/13/2002 | WO2002046204A1 6-0-carbamoyl ketolide derivatives of erythromycin useful as antibacterials |
06/13/2002 | US20020072591 Recovery of isoflavones from soy molasses |
06/13/2002 | CA2431032A1 6-0-carbamoyl ketolide derivatives of erythromycin useful as antibacterials |
06/12/2002 | EP1213296A1 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
06/12/2002 | EP1212337A1 Pesticidal macrolides |
06/12/2002 | EP1212336A2 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
06/12/2002 | EP1212335A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- 4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
06/12/2002 | EP0968222B1 Novel erythromycin derivatives, method of preparation and application as medicines |
06/12/2002 | CN1353694A Alpha-substituted carboxylic acid derivatives |
06/11/2002 | US6403776 Synthesis of carbamate ketolide antibiotics |
06/11/2002 | US6403775 Erythronolide compounds |
06/11/2002 | CA2057441C Synthetic conversion of bryostatin 2 into bryostatin 1 |
06/06/2002 | WO2002044193A1 Method for obtaining azaerythromycin |
06/06/2002 | US20020068332 Generating expression vector coding polyketide synthases; generate nucleotide sequences, obtain cells, transform cells, recover polytketide synthases |
06/05/2002 | EP1211320A2 Methods and compositions for synthesis of oligosacccharides using mutant glycosidase enzymes |
06/04/2002 | US6399789 Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
06/04/2002 | US6399638 Anticarcinogenic agents; microtubule stabilizing effects |
06/04/2002 | US6399582 Ketolide antibacterials |
06/04/2002 | CA1341364C Single polypeptide chain binding molecules |
05/30/2002 | WO2002042315A2 Macrolide solvates |
05/30/2002 | WO2002000663A3 Polycyclic xanthones as antibiotics |
05/30/2002 | WO2001097778A3 Amphotericin b structured emulsion |
05/30/2002 | US20020065235 Ketolide antibiotics |
05/29/2002 | EP1207756A1 Oral treatment of companion animals with ectoparasiticidal spinosyns |
05/29/2002 | EP0799023B1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations |
05/29/2002 | CN1351608A B-methyl-erythromycin derivatives |
05/29/2002 | CN1351607A Novel crystalline forms of macrolide antibiotic |
05/29/2002 | CN1351606A Halo derivatives of 9-Deoxo-9a-Aza-9a-Homery theromycin A |
05/28/2002 | US6395710 Macrolide antiinfective agents |
05/23/2002 | WO2002040036A1 Preventives or remedies for endometriosis or uterine myoma |
05/23/2002 | WO2002009640A3 Process for the preparation of anhydrous azithromycin |
05/23/2002 | US20020061858 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives |
05/22/2002 | EP1206930A2 An oral treatment/care agent |
05/22/2002 | EP1206476A1 9a-azalides with antibacterial activity |
05/22/2002 | EP0888371B1 4,7-dialkoxy-n-acetylneuraminic acid derivatives and methods for detection of influenza type a and b viruses in clinical specimens |
05/22/2002 | CN1349987A Soybean isoflavone and its prepn process with macroporous adsorption resin |
05/22/2002 | CN1085051C Foaming coffee creamer and instant hot cappuccino |
05/21/2002 | US6391594 Generating nucleotide sequence encoding genetically engineered polyketide synthase; obtain nucleotide sequences, insert into expression vectors, transform cells, recover enzymatic polypeptide |
05/16/2002 | WO2002038577A2 Extended release erythromycin derivatives |
05/16/2002 | US20020058803 Preparing preferential compound; incubate sugar with activating agent, couple activated sugar with preferential compound, recover compound |
05/16/2002 | US20020058062 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
05/16/2002 | US20020058013 Bacterial flora-controlling agent; periodontal-pocket bacterial flora-controlling agent that will eliminate or convert the bacteria, fungi, viruses and other microbes into a group of symbiotic bacteria. |
05/16/2002 | CA2425688A1 Extended release erythromycin derivatives |
05/15/2002 | EP1204671A1 Fluorogenic compounds and uses therefor |
05/15/2002 | EP1204670A2 Antibiotic agents |
05/15/2002 | EP0885234B1 Novel erythromycin derivatives, method for preparing same, and use thereof as drugs |
05/15/2002 | EP0873346B1 New crystalline form of morphine-6-glucuronide |
05/14/2002 | US6387885 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists |
05/10/2002 | WO2002036612A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
05/10/2002 | WO2002036602A1 Novel pyrazole derivatives and diabetes remedies containing the same |
05/10/2002 | WO2002036601A2 Phase transfer catalyzed glycosidation of an indolocarbazole |
05/10/2002 | WO2001003681A3 Use of flavones, coumarins and related compounds to treat infections |
05/10/2002 | CA2426815A1 Phase transfer catalyzed glycosidation of an indolocarbazole |
05/10/2002 | CA2426012A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
05/09/2002 | US20020055472 Macrolide antibiotics containing an erythronolide nucleus modified at least at the substituent at C-13 |
05/09/2002 | US20020055465 Nocathiacin antibiotics prepared by biotransformation or chemical methods |
05/07/2002 | US6384211 Library of oligomeric carbopeptoid compounds for use in drug screening; oligomers have at least two carbohydrate amino acid subunits coupled together by an amide linkage |
05/07/2002 | US6384201 Condensing 4'-demethyl-epipodophyllotoxin with a glucopyranose in organic solvent at below-30 degree celsius and in presence of trimethylsilyl triflate catalyst, then converting to etoposide |
05/02/2002 | US20020052390 Treating non-invasive fungus-induced otitis media by mucoadministering an antifungal agent. |
05/02/2002 | US20020052328 Useful as antibacterial and antiprotozoal agents in mammals, including man, as well as in fish and birds. |
05/02/2002 | EP1201677A1 Novel macrolide compound jk |
05/02/2002 | EP1201227A2 Use of flavonoids as immunomodulating or immunoprotecting agents in cosmetic and dermatological compositions |
05/02/2002 | EP1200441A1 Process for making morphine-6-glucuronide and its analogues using haloglucuronate ester intermediates |